Identification of retinol dehydrogenase 10 as a shared biomarker for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus
BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for type 2 diabetes mellitus (T2DM), and its early identification and intervention offer opportunities for reversing diabetes mellitus.MethodsIn this study, we identified biomarkers for the MASLD...
Saved in:
Main Authors: | Fangyu Li, Rui Li, Hongjun Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1521416/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microbiota and metabolic dysfunction associated with steatotic liver disease
by: Q. Zhu, et al.
Published: (2024-09-01) -
The effect of trace minerals on the stability of retinol acetate, cholecalciferol and selenomethionine stability within premixes
by: M. Concarr, et al.
Published: (2021-05-01) -
Effects of Retinol, Natural Pea Peptide and Antioxidant Blend in a Topical Formulation: In Vitro and Clinical Evidence
by: Brian Cook, et al.
Published: (2024-12-01) -
Prediction of MASLD using different screening indexes in Chinese type 2 diabetes mellitus
by: Mengmeng Hu, et al.
Published: (2025-01-01) -
Causal effects of retinol and vitamin D on tongue cancer risk: a mendelian randomization study
by: Jiawei Zhang, et al.
Published: (2025-01-01)